» Articles » PMID: 25900547

Ten-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study

Abstract

It has long been held that schizophrenia and other psychotic disorders have a predominately poor course and outcome. We have synthesized information on mortality, clinical and social outcomes from the ÆSOP-10 multicenter study, a 10-year follow-up of a large epidemiologically characterized cohort of 557 people with first-episode psychosis. Symptomatic remission and recovery were more common than previously believed. Distinguishing between symptom and social recovery is important given the disparity between these; even when symptomatic recovery occurs social inclusion may remain elusive. Multiple factors were associated with an increased risk of mortality, but unnatural death was reduced by 90% when there was full family involvement at first contact compared with those without family involvement. These results suggest that researchers, clinicians and those affected by psychosis should countenance a much more optimistic view of symptomatic outcome than was assumed when these conditions were first described.

Citing Articles

Spatial metabolomics in mental disorders and traditional Chinese medicine: a review.

Lei C, Chen J, Chen Z, Ma C, Chen X, Sun X Front Pharmacol. 2025; 16:1449639.

PMID: 39959419 PMC: 11825820. DOI: 10.3389/fphar.2025.1449639.


Effectiveness of psychological interventions for carers of patients with severe mental illness (SMI): a systematic review.

Ali S, Tallent J, Sambrook H, MacInnes D, Kinane C BMJ Open. 2024; 14(10):e086149.

PMID: 39438102 PMC: 11499822. DOI: 10.1136/bmjopen-2024-086149.


Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).

Farooq S, Hattle M, Kingstone T, Ajnakina O, Dazzan P, Demjaha A Br J Psychiatry. 2024; 225(3):379-388.

PMID: 39101211 PMC: 11536189. DOI: 10.1192/bjp.2024.101.


A Thematic Analysis Investigating the Inaugural Psychosis REACH Family Ambassador Peer Training Program.

Vaswani-Bye A, McCain C, Blank J, Tennison M, Kopelovich S Neuropsychiatr Dis Treat. 2024; 20:233-245.

PMID: 38348058 PMC: 10860596. DOI: 10.2147/NDT.S432255.


User-Centered Development of Bolster, an mHealth Intervention for Early Psychosis Caregivers: Needs Assessment, Prototyping, and Field Trial.

Buck B, Wingerson M, Whiting E, Snyder J, Monroe-DeVita M, Ben-Zeev D JMIR Ment Health. 2023; 10:e50522.

PMID: 38032692 PMC: 10722359. DOI: 10.2196/50522.


References
1.
Saha S, Chant D, McGrath J . A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry. 2007; 64(10):1123-31. DOI: 10.1001/archpsyc.64.10.1123. View

2.
Morgan C, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U . Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol Med. 2014; 44(13):2713-26. PMC: 4134320. DOI: 10.1017/S0033291714000282. View

3.
Thara R, Henrietta M, Joseph A, Rajkumar S, Eaton W . Ten-year course of schizophrenia--the Madras longitudinal study. Acta Psychiatr Scand. 1994; 90(5):329-36. DOI: 10.1111/j.1600-0447.1994.tb01602.x. View

4.
Hoang U, Stewart R, Goldacre M . Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ. 2011; 343:d5422. PMC: 3172324. DOI: 10.1136/bmj.d5422. View

5.
Yang T, Noah A, Shoff C . Exploring geographic variation in US mortality rates using a spatial Durbin approach. Popul Space Place. 2015; 21(1):18-37. PMC: 4310504. DOI: 10.1002/psp.1809. View